Sublingual Misoprostol Versus Standard Surgical Care for the Treatment of Incomplete Abortion in Nigeria
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
Women diagnosed with incomplete abortion in this health facility will be randomized to
receive one of the following regimens: 400 mcg sublingual misoprostol in one dose or standard
surgical treatment (MVA). The investigators hypothesize that treatment of incomplete abortion
with misoprostol using 400 mcg administered sublingually will be as effective as surgical
evacuation.